RNAC Cartesian Therapeutics, Inc. - Common Stock
Cartesian Therapeutics, Inc. - Common Stock 정보 위키백과 회사 개요
RNAC 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
RNAC 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
RNAC 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 5 35.7%
- 매수 8 57.1%
- 보유 1 7.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
7 명의 애널리스트 · 2026-08-17실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $0.46 | $-0.89 | 1.3% |
| 2026년 3월 31일 | $-1.46 | $-0.90 | -0.56% |
| 2025년 12월 31일 | $-3.57 | $-0.87 | -2.7% |
| 2025년 9월 30일 | $-1.38 | $-0.86 | -0.52% |
| 2025년 6월 30일 | $0.50 | $-0.83 | 1.3% |
| 2025년 3월 31일 | $-0.68 | $-0.72 | 0.04% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| SRZN | — | — | — | — | — | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| ZSQR | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $39M | $26M | $111M | $85M | $17M | $7M | $903.0K | · | $8M | $6M | |
| R&D Expense | $58M | $45M | $71M | $72M | $69M | $55M | $43M | $48M | · | $30M | $23M | |
| SG&A Expense | $31M | $30M | $40M | $24M | $21M | $19M | $16M | $18M | · | $13M | $8M | |
| Operating Expenses | $146M | $83M | $112M | $96M | $90M | $73M | $59M | $66M | · | $43M | $31M | |
| Operating Income | $-143M | $-44M | $-86M | $15M | $-5M | $-57M | $-52M | $-65M | · | $-35M | $-25M | |
| Interest Expense | · | · | $3M | $3M | $3M | $2M | $2M | $1M | · | $1M | $948.0K | |
| Interest Income | $7M | $7M | $5M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-2M | $606.0K | $691.0K | $330.0K | $15.0K | $89.0K | $-1M | $10.0K | · | $4.0K | $-26.0K | |
| Pretax Income | $-139M | $-77M | $-239M | $35M | $-10M | $-69M | $-55M | · | · | · | · | |
| Income Tax | $-9M | $287.0K | $-19M | $-609.0K | $16M | $0 | $0 | · | · | · | · | |
| Net Income | $-130M | $-77M | $-220M | $35M | $-26M | $-69M | $-55M | $-65M | · | $-36M | $-25M | |
| EPS (Basic) | $-5.02 | $-4.48 | $-49.76 | $0.24 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · | |
| EPS (Diluted) | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · | |
| Shares (Basic) | 25,973,329 | 17,276,822 | 5,170,319 | 144,758,555 | 114,328,798 | 101,202,176 | 45,548,511 | · | · | · | · | |
| Shares (Diluted) | 25,973,329 | 17,357,943 | 5,170,319 | 145,874,889 | 114,328,798 | 101,202,176 | 45,548,511 | · | · | · | · | |
| EBITDA | $-143M | $-44M | $-86M | $15M | · | $-57M | $-52M | $-65M | · | $-35M | · |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $213M | $77M | $106M | $114M | $139M | $90M | $37M | · | $59M | $32M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $26M | $25M | $4M | |
| Receivables | $1M | $872.0K | $6M | $7M | $10M | $7M | $5M | $0 | $63.0K | $215.0K | $824.0K | |
| Prepaid Expense | $3M | $3M | $5M | $4M | $6M | $5M | $1M | $5M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | $80.0K | · | · | · | |
| Current Assets | $129M | $217M | $91M | $148M | $144M | $151M | $97M | $42M | $99M | $87M | $39M | |
| PP&E (Net) | $12M | $10M | $2M | $3M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $17M | $12M | $8M | $8M | $7M | $6M | $6M | $7M | · | $6M | $5M | |
| Accum. Depreciation | $5M | $2M | $6M | $5M | $5M | $4M | $5M | $5M | · | $4M | $3M | |
| Goodwill | $48M | $48M | $48M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | $518.0K | $0 | · | · | · | · | · | · | $122.0K | $2M | |
| Total Assets | $296M | $435M | $305M | $166M | $160M | $165M | $100M | $44M | $101M | $89M | $43M | |
| Accounts Payable | $1M | $288.0K | $3M | $316.0K | $224.0K | $443.0K | $500.0K | $1M | $2M | $4M | $2M | |
| Accrued Liabilities | $9M | $12M | $15M | $14M | $11M | $8M | $13M | $12M | $9M | $4M | $3M | |
| Current Liabilities | $15M | $23M | $68M | $25M | $72M | $82M | $35M | $35M | $11M | $14M | $7M | |
| Capital Leases | $9M | $11M | $9M | $10M | $9M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $7M | $16M | $16M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $938.0K | $1M | $0 | $290.0K | |
| Total Liabilities | $423M | $442M | $445M | $72M | $137M | $183M | $91M | $50M | $47M | $34M | $22M | |
| Common Stock | $3.0K | $3.0K | $1.0K | $15.0K | $12.0K | $11.0K | $9.0K | $3.0K | $3.0K | $1.0K | $0 | |
| Paid-in Capital | $701M | $690M | $179M | $493M | $457M | $391M | $349M | $280M | $273M | $211M | $1.0K | |
| Retained Earnings | $-822M | $-692M | $-615M | $-395M | $-430M | $-405M | $-336M | $-280M | $-215M | $-152M | $-112M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-4M | $-5M | $-5M | |
| Stockholders' Equity | $-126M | $-7M | $-440M | $94M | $23M | $-18M | $8M | $-5M | $54M | $55M | $-116M | |
| Liabilities + Equity | $296M | $435M | $305M | $166M | $160M | $165M | $100M | $44M | $101M | $89M | $43M | |
| Shares Outstanding | 26,011,106 | 25,767,369 | 5,397,597 | 5,101,459 | 123,622,965 | 108,071,249 | 86,325,547 | 22,471,776 | · | 18,438,742 | 2,173,399 |
현금 흐름 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $23M | $11M | $8M | $5M | $5M | $6M | · | · | · | |
| Deferred Tax | $-9M | $287.0K | $-19M | $0 | $0 | · | · | $0 | · | · | · | |
| Restructuring | $0 | $798.0K | $6M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-74M | $-24M | $-51M | $-32M | $-60M | $35M | $-51M | $-59M | · | $-20M | $-22M | |
| CapEx | $5M | $9M | $206.0K | $1M | $1M | $815.0K | $47.0K | $884.0K | · | $586.0K | $1M | |
| Investing Cash Flow | $-5M | $-9M | $35M | $-15M | $-17M | $-741.0K | $229.0K | $25M | · | $-22M | $-5M | |
| Debt Issued | · | · | · | $0 | $0 | $25M | $0 | $0 | · | · | · | |
| Net Debt Issued | · | $0 | $-27M | $0 | · | $5M | $-3M | $0 | · | $0 | · | |
| Stock Issued | · | · | · | $2M | $52M | $2M | $31M | $0 | · | $3M | $0 | |
| Net Stock Activity | · | · | · | $2M | · | · | $31M | $0 | · | $3M | · | |
| Financing Cash Flow | $-8M | $168M | $-13M | $39M | $53M | $14M | $105M | $697.0K | · | $68M | $44M | |
| Net Change in Cash | $-87M | $136M | $-30M | $-7M | $-25M | $49M | $54M | $-33M | · | $26M | $16M | |
| Free Cash Flow | $-79M | $-33M | $-51M | $-33M | · | $34M | $-51M | $-60M | · | $-20M | · | |
| Levered FCF | · | · | $-54M | $-36M | · | · | · | · | · | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5127.1% | -112.8% | -332.3% | 13.1% | · | -342.4% | -785.6% | -7200.7% | · | -428.9% | · | |
| Net Margin | -4658.6% | -199.0% | -844.9% | 31.9% | · | -415.0% | -829.0% | -7235.4% | · | -448.0% | · | |
| Pretax Margin | -4987.3% | -198.2% | -918.0% | 31.4% | · | · | · | · | · | · | · | |
| EBITDA Margin | -5127.1% | -112.8% | -332.3% | 13.1% | · | -342.4% | -785.6% | -7200.7% | · | -428.9% | · | |
| ROA | -35.6% | -20.9% | -93.3% | 21.7% | · | -52.0% | -76.8% | · | · | -54.8% | · | |
| ROE | 202.4% | 2559.5% | 115.7% | 39.6% | · | 542.6% | -3179.2% | · | · | 117.7% | · | |
| ROIC | 106.1% | 647.8% | 18.1% | 15.8% | · | · | · | · | · | · | · |
유동성 및 지급능력 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.7 | 9.4 | 1.3 | 5.9 | · | 1.9 | 2.8 | · | · | 6.3 | · | |
| Quick Ratio | 8.5 | 9.3 | 1.2 | 4.5 | · | 1.8 | 2.7 | · | · | 6.2 | · | |
| Interest Coverage | · | · | -30.5 | 4.8 | · | -36.5 | -34.5 | -43.5 | · | -27.7 | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.7 | · | 0.1 | 0.1 | · | · | 0.1 | · | |
| Receivables Turnover | 2.8 | 11.5 | 4.2 | 13.4 | · | 2.7 | 2.7 | · | · | 15.6 | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -92.8% | 49.6% | -76.5% | 30.2% | 412.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -70.7% | -22.9% | 16.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -30.0% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $39M | $26M | $111M | $85M | $17M | $7M | $903.0K | · | $8M | · | |
| Net Income TTM | $-130M | $-77M | $-220M | $35M | $-26M | $-69M | $-55M | $-65M | · | $-36M | · | |
| Market Cap | $188M | $461M | $3.35B | $5.19B | · | $9.82B | $6.16B | · | · | $9.49B | · | |
| P/E | -1.4 | -4.0 | -0.4 | 339.0 | -444.5 | -133.7 | -58.5 | · | · | · | · | |
| P/S | 67.1 | 11.9 | 128.7 | 46.8 | · | 591.9 | 923.1 | · | · | 1173.7 | · | |
| P/B | -1.5 | -67.8 | -7.6 | 55.3 | · | -545.6 | 734.0 | · | · | 172.6 | · | |
| P / Tangible Book | · | · | · | 55.3 | 536.8 | · | · | · | · | · | · | |
| P / Cash Flow | -2.5 | -19.5 | -65.4 | -164.0 | · | 281.6 | -119.8 | · | · | -482.0 | · | |
| P / FCF | -2.4 | -14.1 | -65.2 | -158.0 | · | 288.4 | -119.7 | · | · | -468.0 | · | |
| Earnings Yield | -69.6% | -25.1% | -240.7% | 0.29% | -0.22% | -0.75% | -1.7% | · | · | · | · |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $78.0K | $947.0K | $452.0K | $298.0K | $1M | $-759.0K | $387.0K | $33M | $6M | $8M | $7M | $5M | $6M | $17M | $21M | |
| R&D Expense | $20M | $19M | $15M | $14M | $15M | $15M | $11M | $11M | $13M | $10M | $22M | $13M | $18M | $19M | $19M | $17M | |
| SG&A Expense | $9M | $7M | $8M | $8M | $7M | $8M | $7M | $7M | $7M | $9M | $22M | $7M | $6M | $6M | $6M | $6M | |
| Operating Expenses | $29M | $27M | $80M | $22M | $22M | $23M | $26M | $18M | $20M | $19M | $45M | $20M | $24M | $24M | $25M | $22M | |
| Operating Income | $-29M | $-26M | $-79M | $-21M | $-22M | $-22M | $-27M | $-18M | $14M | $-13M | $-36M | $-13M | $-19M | $-18M | $-8M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | $1M | $752.0K | $808.0K | $807.0K | $802.0K | |
| Interest Income | $1M | $1M | · | · | $2M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $126.0K | $-3.0K | $-2M | $0 | $-5.0K | $0 | $-444.0K | $250.0K | $292.0K | $508.0K | $-62.0K | $253.0K | $245.0K | $255.0K | $175.0K | $1.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-197M | $-9M | · | · | $6M | $-8M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-288.0K | $-321.0K | |
| Net Income | $16M | $-39M | $-93M | $-36M | $16M | $-18M | $-10M | $-24M | $14M | $-57M | $-178M | $-9M | $-11M | $-22M | $6M | $-8M | |
| EPS (Basic) | $0.47 | $-1.46 | $-3.47 | $-1.38 | $0.51 | $-0.68 | $6.57 | $-1.13 | $0.58 | $-10.50 | $-41.55 | $-1.74 | $-2.23 | $-4.24 | $0.00 | $-0.05 | |
| EPS (Diluted) | $0.46 | $-1.46 | $-3.46 | $-1.38 | $0.50 | $-0.68 | $6.60 | $-1.13 | $0.54 | $-10.50 | $-41.55 | $-1.74 | $-2.23 | $-4.24 | $0.01 | $-0.05 | |
| Shares (Basic) | 29,467,130 | 26,855,158 | -51,912,475 | 26,002,892 | 25,980,262 | 25,902,650 | -26,332,085 | 21,471,408 | 16,723,479 | 5,414,020 | -10,216,096 | 5,160,150 | 5,114,747 | 5,111,518 | -280,829,965 | 152,849,992 | |
| Shares (Diluted) | 29,860,880 | 26,855,158 | -52,379,464 | 26,002,892 | 26,447,251 | 25,902,650 | -27,318,628 | 21,471,408 | 17,791,143 | 5,414,020 | -10,216,096 | 5,160,150 | 5,114,747 | 5,111,518 | -283,054,317 | 152,849,992 | |
| EBITDA | $-29M | $-26M | · | $-21M | $-22M | $-22M | · | $-18M | $14M | $-13M | · | $-13M | $-19M | $-18M | · | $-2M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $148M | $119M | $125M | $143M | $160M | $180M | $213M | $219M | $87M | $103M | $77M | $80M | $112M | $126M | $106M | $113M | |
| Receivables | $196.0K | $261.0K | $1M | $722.0K | $354.0K | $2M | $872.0K | $5M | $32M | $2M | $6M | $5M | $5M | $7M | $7M | $7M | |
| Prepaid Expense | $6M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $2M | $3M | $5M | $3M | $4M | $4M | $4M | $6M | |
| Current Assets | $154M | $122M | $129M | $147M | $163M | $185M | $217M | $229M | $125M | $111M | $91M | $90M | $123M | $138M | $148M | $160M | |
| PP&E (Net) | $11M | $12M | $12M | $12M | $12M | $10M | $10M | $10M | $7M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $17M | $17M | $17M | $17M | $16M | $13M | $12M | $17M | $13M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Accum. Depreciation | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | |
| Goodwill | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | · | · | · | $0 | · | |
| Other Non-current Assets | · | · | · | · | $6M | $6M | · | · | · | · | $0 | · | · | · | · | · | |
| Total Assets | $319M | $288M | $296M | $373M | $389M | $409M | $435M | $455M | $348M | $325M | $305M | $106M | $140M | $156M | $166M | $178M | |
| Accounts Payable | $1M | $2M | $1M | $2M | $454.0K | $2M | $288.0K | $517.0K | $3M | $3M | $3M | $375.0K | $267.0K | $1M | $316.0K | $214.0K | |
| Accrued Liabilities | $15M | $10M | $9M | $8M | $8M | $9M | $12M | $9M | $11M | $9M | $15M | $14M | $13M | $9M | $14M | $12M | |
| Current Liabilities | $21M | $16M | $15M | $14M | $12M | $15M | $23M | $21M | $26M | $37M | $68M | $20M | $29M | $27M | $25M | $24M | |
| Capital Leases | $7M | $8M | $9M | $9M | $10M | $10M | $11M | $12M | $12M | $8M | $9M | $9M | $9M | $10M | $10M | $11M | |
| Deferred Tax | $7M | $7M | $7M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | · | · | · | $0 | · | |
| Total Liabilities | $444M | $437M | $423M | $409M | $391M | $431M | $442M | $455M | $449M | $442M | $445M | $46M | $74M | $81M | $72M | $93M | |
| Total Debt | $53M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | |
| Paid-in Capital | $725M | $718M | $701M | $699M | $696M | $693M | $690M | $687M | $561M | $559M | $179M | $502M | $498M | $496M | $493M | $490M | |
| Retained Earnings | $-846M | $-862M | $-822M | $-730M | $-694M | $-710M | $-692M | $-682M | $-658M | $-671M | $-615M | $-437M | $-428M | $-417M | $-395M | $-401M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $-125M | $-148M | $-126M | $-36M | $-3M | $-22M | $-7M | $752.0K | $-101M | $-117M | $-440M | $60M | $65M | $75M | $94M | $85M | |
| Liabilities + Equity | $319M | $288M | $296M | $373M | $389M | $409M | $435M | $455M | $348M | $325M | $305M | $106M | $140M | $156M | $166M | $178M | |
| Shares Outstanding | 30,037,962 | 28,544,728 | 26,011,106 | 26,003,606 | 26,000,065 | 25,936,101 | 25,767,369 | 23,896,525 | 17,816,238 | 5,515,836 | 5,397,597 | 154,854,032 | 153,427,571 | 153,426,983 | 153,042,435 | 153,028,822 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $14M | $2M | $4M | $2M | $2M | $3M | |
| Restructuring | · | · | $0 | $0 | $0 | $0 | $21.0K | $-23.0K | $505.0K | $292.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-22M | $-18M | $-16M | $-18M | $-23M | $-7M | $14M | $-14M | $-16M | $-23M | $-9M | $-10M | $-9M | $-12M | $4M | |
| CapEx | $272.0K | $27.0K | $492.0K | $1M | $3M | $1M | $705.0K | $6M | $2M | $602.0K | $64.0K | $0 | $12.0K | $130.0K | $211.0K | $436.0K | |
| Investing Cash Flow | $-272.0K | $-27.0K | $-492.0K | $-1M | $-3M | $-1M | $-354.0K | $-6M | $-2M | $-602.0K | $6M | $0 | $-12.0K | $28M | $5M | $-30M | |
| Stock Issued | $4M | $15M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50M | $16M | $-52.0K | $-38.0K | $60.0K | $-8M | $783.0K | $124M | $120.0K | $43M | $14M | $-25M | $-3M | $149.0K | $0 | $612.0K | |
| Net Change in Cash | $29M | $-6M | $-18M | $-17M | $-20M | $-32M | $-7M | $132M | $-16M | $27M | $-3M | $-34M | $-13M | $19M | $-6M | $-25M | |
| Free Cash Flow | · | $-22M | · | · | · | $-24M | · | · | · | $-17M | · | · | · | $-9M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -33973.1% | · | -4660.6% | -7319.1% | -1989.9% | · | -4541.3% | 41.1% | -228.6% | · | -199.4% | -355.1% | -309.6% | · | -7.7% | |
| Net Margin | · | -50233.3% | · | -7942.9% | 5330.9% | -1610.0% | · | -6248.8% | 41.4% | -973.0% | · | -137.4% | -216.9% | -364.8% | · | -38.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -137.4% | · | · | · | -39.7% | |
| EBITDA Margin | · | -33973.1% | · | -4660.6% | -7319.1% | -1989.9% | · | -4541.3% | 41.1% | -228.6% | · | -199.4% | -355.1% | -309.6% | · | -7.7% | |
| ROA | 4.5% | -11.2% | · | -8.7% | 4.3% | -4.8% | · | -8.6% | 5.7% | -23.6% | · | -6.3% | -7.0% | -14.4% | · | -4.6% | |
| ROE | -24.7% | 46.1% | · | 204.6% | -30.6% | 25.6% | · | -79.2% | -76.8% | 269.2% | · | -12.4% | -14.7% | -33.2% | · | -23.8% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.8% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.5 | 7.7 | · | 10.7 | 13.3 | 12.3 | · | 10.7 | 4.8 | 3.0 | · | 4.5 | 4.2 | 5.2 | · | 6.7 | |
| Quick Ratio | 7.2 | 7.5 | · | 10.4 | 13.1 | 12.1 | · | 10.5 | 4.6 | 2.9 | · | 4.2 | 4.0 | 5.0 | · | 5.0 | |
| Debt / Equity | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -10.3 | -24.8 | -22.7 | · | -2.0 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 0.0 | 0.1 | · | 0.2 | 0.0 | 0.6 | · | 0.1 | 1.8 | 1.3 | · | 1.1 | 0.4 | 0.8 | · | 2.9 |
가치 평가 (TTM) 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $828.0K | $2M | · | $2M | $35M | $41M | · | $46M | $51M | $24M | · | $38M | $71M | $100M | · | $118M | |
| Net Income TTM | $-43M | $-77M | · | $-62M | $-12M | $-85M | · | $-76M | $-63M | $-99M | · | $-50M | $-32M | $8M | · | $12M | |
| Market Cap | $313M | $176M | · | $266M | $270M | $342M | · | $385M | $481M | $108M | · | $4.92B | $5.16B | $6.40B | · | $7.53B | |
| Enterprise Value | $218M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -5.5 | -2.0 | · | -3.8 | -13.5 | -1.1 | · | -1.3 | -1.9 | -1.0 | · | -3.8 | -5.2 | -10.0 | · | -702.9 | |
| P/S | 378.0 | 91.1 | · | 118.8 | 7.7 | 8.4 | · | 8.3 | 9.4 | 4.6 | · | 128.1 | 72.4 | 64.0 | · | 63.6 | |
| P/B | -2.5 | -1.2 | · | -7.4 | -106.9 | -15.7 | · | 512.2 | -4.7 | -0.9 | · | 81.6 | 78.8 | 85.8 | · | 88.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 81.6 | 78.8 | 85.8 | · | 88.7 | |
| P / Cash Flow | · | -7.9 | · | · | · | -14.8 | · | · | · | -6.8 | · | · | · | -729.9 | · | · | |
| P / FCF | · | -7.9 | · | · | · | -14.1 | · | · | · | -6.5 | · | · | · | -719.3 | · | · | |
| EV / EBITDA | -7.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 263.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -18.0% | -49.1% | · | -26.3% | -7.4% | -89.3% | · | -79.6% | -51.6% | -96.0% | · | -26.0% | -19.2% | -10.0% | · | -0.14% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $3M | $39M | $26M | $111M | $85M |
| 영업이익률 % | -5127.1% | -112.8% | -332.3% | 13.1% | — |
| 순이익 | $-130M | $-77M | $-220M | $35M | $-26M |
| 희석 EPS | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 8.7 | 9.4 | 1.3 | 5.9 | — |
| 당좌 비율 | 8.5 | 9.3 | 1.2 | 4.5 | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-79M | $-33M | $-51M | $-33M | — |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 105개의 제출자 · $71.0M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 33 (+9 이전 분기 대비) | 11 (-1 이전 분기 대비) | 37 (+12 이전 분기 대비) | 12 (-2 이전 분기 대비) | +1.6M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
회사 내부자 23 명의 내부자 · 10 임원 · 12 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Carsten Brunn | President & CEO | 2020년 7월 1일 A | — | 0 | 0 | $0 |
| Werner Cautreels | President and CEO | 2016년 6월 21일 A | — | 0 | 0 | $0 |
| David Siewers | Chief Financial Officer | 2016년 6월 21일 A | — | 0 | 0 | $0 |
| Lloyd P. Johnston | COO & SVP, R&D | 2020년 7월 1일 A | 1,606 | 0 | 0 | $0 |
| Metin Kurtoglu | Chief Operations Officer | 2023년 11월 13일 A | — | 0 | 0 | $0 |
| Milos Miljkovic | Chief Medical Officer | 2023년 11월 13일 A | — | 0 | 0 | $0 |
| Christopher M Jewell | Chief Scientific Officer | 2023년 11월 13일 A | — | 0 | 0 | $0 |
| David Abraham | CCO, Gen.Counsel, Corp.Sec. | 2016년 12월 21일 M | 0 | 0 | 0 | $0 |
| Peter Keller | Chief Business Officer | 2016년 12월 19일 S | 405 | 0 | 0 | $0 |
| Earl Sands | Chief Medical Officer | 2016년 6월 21일 A | — | 0 | 0 | $0 |
| Michael Singer | 이사 | 2023년 11월 13일 J | 7,616 | 0 | 0 | $0 |
| Murat Kalayoglu | 이사 | 2023년 11월 13일 P | 3,303,699 | 0 | 0 | $0 |
| Scott Dunseth Myers | 이사 | 2019년 12월 23일 A | 80,845 | 0 | 0 | $0 |
| Timothy C Barabe | 이사 | 2019년 12월 23일 A | 83,173 | 0 | 0 | $0 |
| COX CARRIE SMITH | 이사 | 2019년 12월 23일 A | 65,681 | 0 | 0 | $0 |
| Timothy A. Springer | 이사 | 2019년 12월 23일 A | 5,486,463 | 0 | 0 | $0 |
| Amir Nashat | 이사 | 2019년 1월 25일 P | 2,676,234 | 0 | 0 | $0 |
| Edwin M Kania JR | 이사 | 2017년 5월 16일 S | 560,067 | 0 | 0 | $0 |
| Omid Farokhzad | 이사 | 2017년 3월 23일 M | 188,004 | 0 | 0 | $0 |
| GORDON CARL L | 이사 | 2016년 6월 27일 C | 1,825,415 | 0 | 0 | $0 |
| RUSNANO | 10% 소유주 | 2016년 6월 27일 C | 1,476,177 | 0 | 0 | $0 |
| Bradford D. Dahms | — | 2020년 7월 1일 A | — | 0 | 0 | $0 |
| Takashi Kei Kishimoto | — | 2016년 12월 28일 M | 0 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Murat Kalayoglu, Seven One Eight Three Four Irrevocable Trust, Elizabeth Hoge, Sinan Kalayoglu ×4 제출 서류 | 2026년 4월 2일 | 19.90% | 수정본 | — | SEC |
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×20 제출 서류 | 2025년 1월 15일 | 36.90% | 수정본 | — | SEC |
| Michael Singer, Thirsty Brook 2010 Irrevocable Trust, Singer Asefzadeh Family Holding Trust, Bakezilla 2019 Irrevocable Trust, Baharak Asefzadeh, Barbara P. Martin ×2 제출 서류 | 2024년 4월 10일 | — | 최초 제출 | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire, Amir Nashat ×5 제출 서류 | 2020년 2월 12일 | — | 최초 제출 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×6 제출 서류 | 2020년 2월 5일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 16 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.58% | 14,831 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.03% | 44,124 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 10,285 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.01% | 93,935 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.00% | 331,773 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.00% | 4,929 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.00% | 494 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.00% | 386 NS | 2026년 5월 31일 | N-PORT |
| IWO · iShares Trust | 0.00% | 16,635 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.00% | 390 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 11 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 169,730 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 376,309 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 74,975 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,441 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 616 SH | 2026년 8월 8일 | 일간 |